18.1102.63% ( -0.490 )
Trading: Nov 16, 12:58:43 (EDT)Profile
About

Mentari Therapeutics
MTRI.US
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company’s products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.
Profile
- Company Name
- Mentari Therapeutics, Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.mentaritx.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
